RENAISSANCE TECHNOLOGIES LLC
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1037389
NEW YORK, NY
Position in AUPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,270,153
+$1,612,119 QoQ
Shares Held
1,548,035
-7.0% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#11
of 279 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. AUPH ranks #27 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in AUPH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,270,153 | 1,548,035 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,658,034 | 1,663,835 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,362,653 | 1,590,135 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,018,080 | 1,449,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,806,566 | 1,157,800 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,546,344 | 938,600 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,294,082 | 700,900 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,567,511 | 486,700 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,150,565 | 201,500 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,225,446 | 244,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,213,650 | 135,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,151,510 | 663,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,814,272 | 1,530,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $17,362,832 | 1,584,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,141,824 | 1,653,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,518,176 | 733,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,015,930 | 598,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,974,196 | 1,694,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,681,913 | 467,071 | Shares | Sole | 2022-02-11 | |
| 2020-09-30 | $3,526,362 | 239,400 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $18,809,375 | 1,157,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $20,876,988 | 1,438,800 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||